RJ
Therapeutic Areas
Drive Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Aptamer Program | Wet Age-Related Macular Degeneration (wAMD) | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Aptamer Program | Wet Age-Related Macular Degeneration (wAMD) | Pre-clinical |